@article{cca802f01e7d4b7c99de46f004ede248,
title = "Comment: Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine [3] (multiple letters)",
keywords = "dopamine 2 receptor, haloperidol, olanzapine, risperidone, drug efficacy, drug potency, extrapyramidal symptom, human, incidence, letter, priority journal, receptor occupancy, risk assessment",
author = "Mong-Liang Lu and Shen, {Winston W.} and Igor Schillevoort and {De Boer}, Anthonius and Roos, {Raymund A.C.} and Jansen, {Paul A.F.} and Leufkens, {Hubert G.M.}",
year = "2002",
month = mar,
day = "9",
language = "English",
volume = "36",
pages = "1292--1293",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "SAGE Publications Inc.",
number = "7-8",
}